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any manuscript also demands integrity from reviewers, editors and publishers, who have to be seen to act impartially and promptly in reaching their decisions.
The combination of increased editor awareness and change in author behavior has resulted in an escalation in the number of papers retracted from the scientific literature (Fanelli, 2013; Steen et al., 2013) . Misconduct is responsible for more than two thirds of the ~2,000 or so retracted articles indexed in PubMed articles (Fang et al., 2012) . Another recent analysis of this collection of papers (~700 published prior to, and ~1,300 after 2002) concluded that the increase in retractions reflects a change in the behavior of both authors and institutions . Questionable articles appear to overcome progressively lower barriers to publication, as evidenced recently when more than half of over 300 open-access journals accepted the bogus and hopelessly flawed submission from a certain 'Ocorrafoo Cobange' at the 'Wassee Institute of Medicine' (Bohannon, 2013) . Plagiarism (in all its forms), once excused as a mistake, is now identified as a misdeed (Sala et al., 2013) Neurochemistry over a period of three weeks were found to contain not only overlapping material, but also data highly similar to papers previously published in other journals.
Authorship attribution on this collection of published and unpublished papers was highly suspect, to the extent that some of the email addresses turned out to be fictitious. The efforts that an Editorial Office has to take to ensure research integrity and to uncover fraudulent behavior, e.g. by asking each co-author to confirm their authorship, strains the majority of honest researchers. Notably, while retraction carries a stigma, not all retractions are due to scientific misconduct. To protect scientific integrity and the reputation of honest scientists, retraction notices or corrigenda need to state explicitly the reasons and evidence for the action. Since other researchers rely on reported findings, general statements such as "due to an error in the reported data" should be avoided (http://retractionwatch.com/2013/04/26/a-model-retraction-in-the-journal-ofneurochemistry-for-unexpected-effect-of-a-filter).
Recycling data and text from one's own or others' published manuscripts is not allowed, no matter what language or format the data are presented in. Exceptions are when an author subsequently submits data to an educational establishment as part of a
This article is protected by copyright. All rights reserved. (Barboza et al., 2013) , this contradicts publication ethics unless the original is properly attributed.
Uncovering plagiarism, either in a submitted ms. or in a published paper, results in a penalty. Depending on the severity of the case, in Journal of Neurochemistry this can result in a ban on future article submissions for up to 8 years, retraction of the published paper, and a report sent to the authors' institutions. There is no statute of
This article is protected by copyright. All rights reserved. Image manipulation has become increasingly sophisticated, but it is also more readily identifiable by means of image software. In our own particular scientific field, western blots have become highly questionable currency, as these can be cropped, While image manipulation is quite transparent, data fabrication is much more difficult to detect unless statistical analysis of the distribution of the data points reveals anomalies (Yong et al., 2013) . Ultimately, it is a 'failure to repeat' that throws doubt on the veracity of published data. In a clutch of related papers from one laboratory, fictional mouse genotypes generated the data (Fed. Reg. 2012-28209) . A recent statement of concern in Anesthesia and Analgesia reported on an individual at Toho University in
Tokyo who fabricated data in 172 publications, never seeing the 'patients' recorded, failing to get ethical approval, and using colleagues as co-authors without their knowledge. Selective reporting and manipulation of data in pre-clinical (www.aptuit.com/aptuit60/images/MHRAStatement.pdf) and clinical trials (www.pharmatimes.com) could easily lead to the release of dangerous products and did result in the closure of a research facility. Infamously, altered medical histories of trials' patients in the UK led to a flawed publication questioning the safety of MMR vaccination (Wakefield et al., 1998) . market also seems to be operating (Hvistendahl, 2013) . And what happens to those found guilty? It seems that >50% of more senior authors retain careers in science and continue to publish. Younger members of the laboratory are affected more than the senior investigator, publishing an average of only one paper a year after misconduct determinations (Redman and Merz, 2013) . However, it is often the senior investigator
who has to take final responsibility when former laboratory members have left the institution and cannot be contacted.
What can journals do to police submissions and pre-empt retraction? Electronic surveillance, eagle-eyed reviewers and editors, and 'whistle-blowers' each play a role. It also seems highly likely that editors maintain names on a blacklist. In recent years, journals have become more willing to consider publication of negative findings (Dirnagl and Lauritzen, 2010) , to reduce publication bias. Hopefully, this will also remove 'publication pressure' on authors to make something more of the data than is warranted.
The consequences of presenting poor data, whether by intent or bad practice, are becoming all too clear. Lack of reproducibility is leading major agencies, such as National Institutes for Health, to consider spending some of their dwindling budget on verifying the data that, in many instances, they have already paid for (Wadman, 2013) .
While this serves as 'notice' for how seriously Journal of Neurochemistry takes the issue of scientific misconduct, the point is that manipulating data and text for publication is a self-defeating exercise, as the ensuing post-publication scrutiny guarantees eventual discovery. Simply put, science progresses only through the integrity of all involved, otherwise it becomes merely an (expensive) exercise in futility.
